Higher Respiratory Complications in Alcoholic Hepatitis Patients With Hepatorenal Syndrome When Treated With Terlipressin: Is it Safe?

Clin Gastroenterol Hepatol. 2023 Nov;21(12):3197-3198. doi: 10.1016/j.cgh.2023.03.037. Epub 2023 Apr 7.

Authors

Kishore Kumar Ariga¹, Govind Verma², Dhiraj Agrawal³

Affiliations

¹ Department of Nephrology, PACE Hospitals, Hitec City, Hyderabad, India.
² Department of Gastroenterology, PACE Hospitals, Hitec City, Hyderabad, India.
³ Department of Gastroenterology and Hepatology, PACE Hospitals, Hitec City, Hyderabad, India.

PMID: 37031717
DOI: 10.1016/j.cgh.2023.03.037

No abstract available

Publication types

Letter
Comment

MeSH terms

Hepatitis, Alcoholic* / complications
Hepatitis, Alcoholic* / drug therapy
Hepatorenal Syndrome* / complications
Hepatorenal Syndrome* / drug therapy
Humans
Lypressin / adverse effects
Terlipressin* / therapeutic use
Treatment Outcome
Vasoconstrictor Agents* / therapeutic use

Substances

Lypressin
Terlipressin
Vasoconstrictor Agents